BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hansen K, Horslen S. Metabolic liver disease in children. Liver Transpl 2008;14:713-33. [PMID: 18433056 DOI: 10.1002/lt.21520] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Khanna R, Alam S, Rastogi A, Sharma CB. Neonatal cholestasis with ductal paucity and steatosis. Indian Pediatr 2013;50:316-20. [DOI: 10.1007/s13312-013-0073-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Arnon R, Annunziato RA, Miloh T, Padilla M, Sogawa H, Batemarco L, Willis A, Suchy F, Kerkar N. Liver and combined lung and liver transplantation for cystic fibrosis: Analysis of the UNOS database: Liver transplantation for cystic fibrosis. Pediatric Transplantation 2011;15:254-64. [DOI: 10.1111/j.1399-3046.2010.01460.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
3 Skvorak KJ, Hager EJ, Arning E, Bottiglieri T, Paul HS, Strom SC, Homanics GE, Sun Q, Jansen EE, Jakobs C, Zinnanti WJ, Gibson KM. Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta 2009;1792:1004-10. [PMID: 19699299 DOI: 10.1016/j.bbadis.2009.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
4 Mazariegos G, Shneider B, Burton B, Fox IJ, Hadzic N, Kishnani P, Morton DH, McIntire S, Sokol RJ, Summar M, White D, Chavanon V, Vockley J. Liver transplantation for pediatric metabolic disease. Mol Genet Metab 2014;111:418-27. [PMID: 24495602 DOI: 10.1016/j.ymgme.2014.01.006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
5 Vo HD, Xu J, Rabinowitz SS, Fisher SE, Schwarz SM. The Liver in Pediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology & Nutrition 2014;59:288-99. [DOI: 10.1097/mpg.0000000000000444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kaiser RA, Mao SA, Glorioso J, Amiot B, Nicolas CT, Allen KL, Du Z, VanLith CJ, Hickey RD, Nyberg SL, Lillegard JB. Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine. J Vis Exp 2018. [PMID: 30451238 DOI: 10.3791/58399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Herrmann U, Dockter G, Lammert F. Cystic fibrosis-associated liver disease. Best Pract Res Clin Gastroenterol. 2010;24:585-592. [PMID: 20955961 DOI: 10.1016/j.bpg.2010.08.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
8 Burfield J, Hussa C, Randall R. Hot Topics in Metabolism: A Focus on Phenylketonuria, Liver Transplantation, and Galactosemia. Topics in Clinical Nutrition 2012;27:181-95. [DOI: 10.1097/tin.0b013e318262cebf] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Rook M, Rosenthal P. Caring for adults with pediatric liver disease. Curr Gastroenterol Rep. 2009;11:83-89. [PMID: 19166664 DOI: 10.1007/s11894-009-0013-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
10 Harding CO, Gibson KM. Therapeutic liver repopulation for phenylketonuria. J Inherit Metab Dis 2010;33:681-7. [PMID: 20495959 DOI: 10.1007/s10545-010-9099-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
11 Su K, Donaldson E, Sharma R. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa. Appl Clin Genet 2016;9:157-67. [PMID: 27799810 DOI: 10.2147/TACG.S86760] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Vaghjiani V, Vaithilingam V, Saraswati I, Sali A, Murthi P, Kalionis B, Tuch BE, Manuelpillai U. Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro. Stem Cells Dev 2014;23:866-76. [PMID: 24295364 DOI: 10.1089/scd.2013.0485] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
13 El-Hachem N, Grossmann P, Blanchet-Cohen A, Bateman AR, Bouchard N, Archambault J, Aerts HJ, Haibe-Kains B. Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms. Environ Health Perspect 2016;124:313-20. [PMID: 26173225 DOI: 10.1289/ehp.1409157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
14 Thompson WS, Mondal G, Vanlith CJ, Kaiser RA, Lillegard JB. The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism. Expert Opin Orphan Drugs 2020;8:245-56. [PMID: 33224636 DOI: 10.1080/21678707.2020.1791082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hickey RD, Mao SA, Glorioso J, Lillegard JB, Fisher JE, Amiot B, Rinaldo P, Harding CO, Marler R, Finegold MJ, Grompe M, Nyberg SL. Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res 2014;13:144-53. [PMID: 24879068 DOI: 10.1016/j.scr.2014.05.003] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
16 Jeyaraj R, Bounford KM, Ruth N, Lloyd C, MacDonald F, Hendriksz CJ, Baumann U, Gissen P, Kelly D. The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges. Genes (Basel) 2021;12:1837. [PMID: 34828443 DOI: 10.3390/genes12111837] [Reference Citation Analysis]
17 Pournasr B, Duncan SA. Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells. Arterioscler Thromb Vasc Biol 2017;37:1994-9. [PMID: 28818857 DOI: 10.1161/ATVBAHA.117.309199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
18 Pierre G, Chronopoulou E. Metabolic disorders presenting as liver disease. Paediatrics and Child Health 2013;23:509-15. [DOI: 10.1016/j.paed.2013.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kamath BM, Olthoff KM. Liver transplantation in children: update 2010. Pediatr Clin North Am. 2010;57:401-414, table of contents. [PMID: 20371044 DOI: 10.1016/j.pcl.2010.01.012] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
20 Balwani M, Breen C, Enns GM, Deegan PB, Honzík T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schneider E, Quinn AG. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology 2013;58:950-7. [PMID: 23348766 DOI: 10.1002/hep.26289] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 7.9] [Reference Citation Analysis]
21 Maymó JL, Riedel R, Pérez-Pérez A, Magatti M, Maskin B, Dueñas JL, Parolini O, Sánchez-Margalet V, Varone CL. Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation. PLoS One 2018;13:e0191489. [PMID: 29346426 DOI: 10.1371/journal.pone.0191489] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
22 Stelten BML, Dotti MT, Verrips A, Elibol B, Falik-Zaccai TC, Hanman K, Mignarri A, Sithole B, Steiner RD, Verma S, Yahalom G, Zubarioglu T, Mochel F, Federico A. Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study. Orphanet J Rare Dis 2021;16:353. [PMID: 34362411 DOI: 10.1186/s13023-021-01980-5] [Reference Citation Analysis]
23 Guilder L, Pula S, Pierre G. Metabolic disorders presenting as liver disease. Paediatrics and Child Health 2017;27:533-9. [DOI: 10.1016/j.paed.2017.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Ng VL, Mazariegos GV, Kelly B, Horslen S, Mcdiarmid SV, Magee JC, Loomes KM, Fischer RT, Sundaram SS, Lai JC, Te HS, Bucuvalas JC. Barriers to ideal outcomes after pediatric liver transplantation. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
25 Hickey RD, Mao SA, Glorioso J, Elgilani F, Amiot B, Chen H, Rinaldo P, Marler R, Jiang H, DeGrado TR, Suksanpaisan L, O'Connor MK, Freeman BL, Ibrahim SH, Peng KW, Harding CO, Ho CS, Grompe M, Ikeda Y, Lillegard JB, Russell SJ, Nyberg SL. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. Sci Transl Med 2016;8:349ra99. [PMID: 27464750 DOI: 10.1126/scitranslmed.aaf3838] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]